How to Get Fosamax (Alendronate) in Alabama

What Alendronate (Fosamax) Actually Does

Alendronate is a nitrogen-containing bisphosphonate that binds to hydroxyapatite on bone surfaces and inhibits osteoclast-mediated resorption. The net result is a measurable increase in bone mineral density (BMD) at the lumbar spine, femoral neck, and total hip over 12 to 36 months of treatment. The standard prescription is 70 mg taken orally once every seven days, first thing in the morning, with a full 8-oz glass of plain water and at least 30 minutes before food, drink, or other medications.

The FDA approved alendronate for postmenopausal osteoporosis in 1995, and the approval label remains accessible on the FDA website (FDA prescribing information). Merck originally marketed the drug as Fosamax, but patents have long expired. Every major pharmacy chain in Alabama stocks generic alendronate 70 mg tablets.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 with 2,027 postmenopausal women who had low femoral-neck BMD, found that alendronate reduced the risk of hip fracture by 51% and vertebral fracture by 47% over three years compared with placebo (Black DM et al., JAMA 1998). Those reductions translate to real clinical events prevented, not just numbers on a DEXA printout.

Alabama has the 10th-highest age-adjusted osteoporosis hospitalization rate in the United States, according to CDC state-level fracture data (CDC, Osteoporosis Data). Access to effective, inexpensive treatment like alendronate is therefore a meaningful public-health concern for the state.

Who Qualifies for an Alendronate Prescription in Alabama

Prescribers in Alabama follow the National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation) guidelines alongside the American Association of Clinical Endocrinologists (AACE) 2020 Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis (AACE, 2020).

The standard indications for alendronate are:

• A DEXA T-score of -2.5 or lower at the lumbar spine, femoral neck, or total hip (osteoporosis diagnosis)
• A DEXA T-score between -1.0 and -2.5 (osteopenia) combined with a 10-year FRAX hip fracture probability of 3% or greater, or a major osteoporotic fracture probability of 20% or greater
• Any prior low-trauma fragility fracture at the hip or spine, regardless of T-score

Men with osteoporosis are also candidates. The FDA label includes treatment of glucocorticoid-induced osteoporosis for men and women receiving daily prednisone-equivalent doses of 7.5 mg or more. Alendronate is not appropriate for patients with creatinine clearance <35 mL/min, uncorrected hypocalcemia, or an inability to sit or stand upright for at least 30 minutes after ingestion.

The AACE guideline states: "Bisphosphonates are recommended as first-line pharmacological therapy for most patients with postmenopausal osteoporosis at high fracture risk." That recommendation places alendronate, alongside risedronate and zoledronic acid, at the front of the prescribing decision tree.

What Labs and Tests You Need Before Starting

Before any Alabama prescriber writes an alendronate prescription, they will typically order a structured baseline workup. The checklist below reflects what most physicians, telehealth providers, and endocrinologists require.

DEXA Scan. A dual-energy X-ray absorptiometry scan documenting T-scores at the lumbar spine (L1-L4) and left hip is the cornerstone of diagnosis. Alabama Medicare beneficiaries are covered for a DEXA every 24 months. Many commercial plans cover it annually for high-risk patients. Walk-in DEXA at imaging centers in Birmingham, Huntsville, Mobile, and Montgomery typically costs $75 to $150 out-of-pocket.

Basic Metabolic Panel (BMP). Prescribers check serum calcium, phosphate, and creatinine. Hypocalcemia must be corrected before the first dose to avoid symptomatic worsening. A creatinine <35 mL/min on estimated GFR is a contraindication (FDA prescribing information).

25-Hydroxyvitamin D. Low vitamin D (below 30 ng/mL) is extremely common in Alabama despite its southern latitude; indoor lifestyles and high rates of obesity reduce cutaneous synthesis. Correcting vitamin D before starting alendronate prevents the risk of drug-induced hypocalcemia. Most prescribers target 25-OH D levels between 30 and 50 ng/mL (NIH Office of Dietary Supplements, Vitamin D).

Dental Review. Because osteonecrosis of the jaw (ONJ) is a rare but serious adverse effect of bisphosphonate therapy, prescribers typically ask about recent dental procedures and recommend completing any planned invasive dental work before starting long-term alendronate. The absolute risk of ONJ in patients taking oral bisphosphonates for osteoporosis is estimated at 1 in 10,000 to 1 in 100,000 patient-years (Khosla S et al., J Bone Miner Res).

Parathyroid Hormone (PTH) and Thyroid Function. These are optional but often ordered when secondary causes of bone loss are suspected, for instance in younger patients or those with unusually rapid BMD decline.

A telehealth prescriber can review uploaded DEXA reports and lab results electronically without an in-person visit, making the process entirely compatible with Alabama's telehealth framework.

How Alabama's Telehealth Laws Apply to Alendronate Prescribing

Alabama permits telehealth prescribing of non-controlled legend drugs, and alendronate is a non-controlled prescription medication. The Alabama Telehealth Act (Act 2015-542, updated under SB 101 in 2021) allows licensed Alabama physicians, nurse practitioners with prescriptive authority, and physician assistants to establish a valid patient-prescriber relationship via synchronous audio-video technology (Alabama Board of Medical Examiners).

This means a patient living in rural Talladega County, Cullman, or Dothan, where endocrinology wait times can stretch beyond four months, can complete a telehealth visit from home, upload their DEXA report and lab results, and receive an alendronate prescription the same day. The prescription can be sent electronically (e-prescribed) to any Alabama pharmacy or to a mail-order pharmacy.

Telehealth platforms that hold Alabama prescribing licenses include both national services and Alabama-based practices. HealthRX providers are licensed in Alabama and can conduct an initial bone-health evaluation, review existing DEXA and lab data, and prescribe alendronate when clinically appropriate. A follow-up telehealth visit at 12 months to review a repeat DEXA and assess tolerability is consistent with AACE monitoring guidelines.

One practical note: the visit must be synchronous (live video) for an initial prescription in Alabama. Asynchronous or store-and-forward evaluations alone are not sufficient to establish a new patient-prescriber relationship under Alabama Board of Medical Examiners policy.

Where to Fill a Fosamax or Alendronate Prescription in Alabama

Generic alendronate 70 mg tablets are in stock at virtually every retail pharmacy chain operating in Alabama, including CVS, Walgreens, Walmart, Winn-Dixie, and Publix, as well as independent community pharmacies. The GoodRx cash price in Alabama ZIP codes ranges from approximately $9.00 to $18.00 for a 4-tablet (28-day) supply as of early 2025, making it one of the most affordable prescription osteoporosis medications available.

503A Compounding Pharmacies. Alabama-licensed 503A compounding pharmacies may prepare customized formulations of alendronate, for example a liquid suspension for patients who cannot swallow tablets or who have documented esophageal sensitivity to the standard tablet. 503A pharmacies in Alabama operate under state Board of Pharmacy oversight and must compound only in response to a valid patient-specific prescription. They may ship within Alabama; interstate shipping requires compliance with destination-state law.

Mail-Order Pharmacies. National mail-order pharmacies (including those operated by Express Scripts, CVS Caremark, and OptumRx) ship alendronate to Alabama addresses. A 90-day supply through a PBM mail-order program frequently costs $0 to $5 for insured patients with Tier 1 generic coverage.

Medication Assistance. For uninsured patients, Merck historically offered patient-assistance programs for branded Fosamax, though the generic is now so inexpensive that cash payment is often more practical than a formal assistance program application. Patients earning below 200% of the federal poverty level may qualify for assistance through local federally qualified health centers (FQHCs) in Alabama, which receive 340B drug pricing.

Insurance Coverage and Prior Authorization in Alabama

Commercial Insurance. Most commercial plans in Alabama place generic alendronate on Tier 1 (preferred generic), meaning a 30-day supply costs $0 to $10 as a copay. Prior authorization is not routinely required for generic alendronate when the ICD-10 diagnosis code M81.0 (age-related osteoporosis without current pathological fracture) is billed correctly.

Medicare Part D. CMS data show alendronate 70 mg is included on virtually every Medicare Part D formulary at the lowest cost tier. The Medicare "coverage gap" (donut hole) has minimal impact on a drug whose standard retail cost is already under $20. Beneficiaries who have had a DEXA confirming osteoporosis and whose prescriber documents a diagnosis of M81.0 or M80.00 (with pathological fracture) should encounter no prior-authorization barrier.

Alabama Medicaid. As of the date of this article, the Alabama Medicaid Agency does not cover alendronate for osteoporosis under its standard preferred drug list. Prescribers seeking coverage for Medicaid-enrolled patients must submit a prior-authorization request documenting DEXA T-score results, fracture history, and clinical necessity. Required documentation typically includes the DEXA report with T-scores, the FRAX calculation printout, and a letter of medical necessity from the treating provider. Approval is not guaranteed; denial rates vary by region.

The table below summarizes a practical prior-authorization evidence package that Alabama prescribers can assemble to support a Medicaid PA request for alendronate.

Alabama Medicaid Prior-Authorization Evidence Package for Alendronate

1. DEXA report showing T-score at lumbar spine and/or hip (date within 24 months)
2. FRAX 10-year fracture probability calculation (hip and major osteoporotic fracture fields completed)
3. Serum calcium and creatinine confirming no contraindication
4. 25-OH vitamin D result with current supplementation plan
5. Letter of medical necessity from prescribing provider with ICD-10 code
6. Documentation of fracture history if applicable (imaging or radiology report)
7. Denial or step-therapy documentation if plan requires prior failure of another agent

Assembling all seven elements before submitting reduces back-and-forth request cycles, which typically add 14 to 21 days to access in the Alabama Medicaid system.

Who Can Prescribe Alendronate in Alabama

Alabama law grants prescriptive authority for non-controlled legend drugs to several licensed practitioner types.

Physicians (MD and DO). Primary care physicians, internists, gynecologists, rheumatologists, endocrinologists, and orthopedic surgeons all prescribe alendronate routinely. No special certification is required beyond a valid Alabama medical license.

Nurse Practitioners (NPs). Alabama NPs with a Certificate of Fitness (COF) issued by the Alabama Board of Nursing hold independent prescriptive authority for Schedule III-V controlled substances and all non-controlled legend drugs, effective under Act 2013-261 as amended. An NP operating a telehealth bone-health service in Alabama can prescribe alendronate without physician co-signature, provided the NP holds an active COF and the visit meets telehealth standards.

Physician Assistants (PAs). Alabama PAs may prescribe non-controlled legend drugs under a written job description agreement with a supervising physician. The supervising physician does not need to be present during a telehealth visit, but must be available for consultation. A PA employed by a telehealth platform with an Alabama supervising agreement can therefore prescribe alendronate.

Dentists. Alabama dentists are not authorized to diagnose or treat systemic osteoporosis, but they play a role in pre-treatment dental clearance. Some dental teams proactively flag patients on bisphosphonates to monitor for medication-related osteonecrosis of the jaw (MRONJ).

Transferring an Existing Fosamax Prescription to Alabama

Patients who move to Alabama from another state, or who establish care with an Alabama provider after previously receiving alendronate out-of-state, have two practical options.

Pharmacy Transfer. Most chain pharmacies can transfer a non-controlled prescription from an out-of-state pharmacy to an Alabama location, provided the prescription has remaining refills and the original prescriber holds an active license in the originating state. Alabama does not require the prescribing physician to hold an Alabama license for a valid out-of-state non-controlled prescription to be filled within the state, although individual pharmacy policies vary.

New Alabama Prescription. The cleaner path, particularly for telehealth patients, is a new evaluation with an Alabama-licensed provider. If the patient brings their most recent DEXA report, current lab results (dated within 12 months), and a list of current medications, most telehealth visits can be completed in 20 to 30 minutes and generate an Alabama e-prescription the same day. This eliminates any ambiguity about prescription validity and establishes a documented patient-prescriber relationship for ongoing refills.

Documentation to Bring. Patients transferring care should gather: the most recent DEXA report, any prior vertebral imaging, current medications list, insurance card, and records of any prior adverse effects or dental procedures during bisphosphonate use.

Monitoring and Long-Term Management in Alabama

Starting alendronate is only part of the treatment picture. AACE and the American Society for Bone and Mineral Research (ASBMR) recommend a structured monitoring plan (ASBMR Task Force, JBMR 2016).

A repeat DEXA at 12 to 24 months documents BMD response. Patients who show a meaningful gain (typically more than 3% at the lumbar spine, exceeding the least significant change for the specific scanner) are confirmed as responding. Patients who show continued BMD decline despite confirmed adherence may need evaluation for secondary causes or a switch to a more potent agent such as zoledronic acid 5 mg IV annually or denosumab 60 mg subcutaneously every 6 months.

After 3 to 5 years of alendronate use, the ASBMR recommends a "drug holiday" reassessment. Patients at low or moderate fracture risk (hip T-score above -2.5, no prior hip or spine fracture) can discontinue alendronate for 2 to 3 years while the drug's residual skeletal binding provides continued protection. High-risk patients, defined as those with a hip T-score below -2.5 or a prior fragility fracture, should generally continue therapy or transition to an alternative agent.

Atypical femoral fracture (AFF) is a rare but recognized complication of long-term bisphosphonate use, with an estimated incidence of 3.2 to 50 cases per 100,000 patient-years depending on duration of use (Shane E et al., JBMR 2014). Patients who develop prodromal thigh or groin pain during alendronate therapy should have bilateral femoral X-rays ordered promptly.

Alabama patients using telehealth services should ensure their monitoring DEXA is scheduled at a local imaging center and that results are transmitted electronically to their telehealth provider before the follow-up appointment, minimizing delays.

Step-by-Step: Getting Alendronate in Alabama Today

The process from symptom recognition to first dose can realistically be completed within 7 to 14 days for most Alabama patients who approach it systematically.

Step 1. Schedule a DEXA scan. Call a local imaging center or ask your primary care physician for a referral. DEXA scans are available in most Alabama counties; rural patients may need to travel to a regional medical center. Results are typically available within 1 to 3 business days.

Step 2. Get baseline labs. A basic metabolic panel and 25-OH vitamin D can be ordered by any prescriber or drawn at a commercial lab (LabCorp and Quest both operate in Alabama). Results return within 24 to 48 hours in most cases.

Step 3. Book a telehealth or in-person visit. Upload your DEXA report and lab results to the telehealth portal before the visit. HealthRX providers can review the records asynchronously before the live video appointment, shortening visit time.

Step 4. Receive your e-prescription. After the visit, the prescriber sends the prescription electronically to your preferred Alabama pharmacy or mail-order service. Most pharmacies fill alendronate the same day.

Step 5. Start correctly. Take the 70 mg tablet on the same day each week, first thing in the morning, with 8 oz of plain water only. Stay upright (sitting or standing) for at least 30 minutes. Do not take calcium supplements, antacids, or food within 30 minutes of the dose.

Step 6. Follow up at 12 months. Schedule a repeat DEXA. Bring or upload results to your provider for a monitoring visit.

For patients whose 25-OH vitamin D is below 20 ng/mL, the prescriber will typically recommend correcting the deficiency with cholecalciferol (vitamin D3) 2,000 to 4 to 000 IU daily for 8 to 12 weeks before starting alendronate, reducing the risk of drug-induced hypocalcemia.